Alternaria, a naturally occurring plant pathogen, may rarely cause infection in immunocompromised patients. This report describes a case of invasive alternariosis in a 33-year-old patient with acute leukemia.
GarauJ., DiamondR.D., LagrotteriaL.B., KabinsS.A.Alternaria osteomyelitis. Evidence of specific immunologic tolerance. Ann Intern Med86: 747–748, 1977.
4.
GoodpastureH.C., CarlsonT., EllisB., RandallG.Alternaria osteomyelitis. Evidence of specific immunologic tolerance. Arch Pathol Lab Med107: 528–530, 1983.
MorganM.A., WilsonW.R., NeelHBIII, RobertsG.D.Fungal sinusitis in healthy and immunocompromised individuals. Am J Clin Pathol82: 597–601, 1984.
9.
ArmstrongD., YoungL.S., MeyerR.D., BlevinsA.H.Infectious complications of neoplastic disease. Med Clin North Am55: 729–745, 1971.
10.
JonesM.E., SaleemA.Acute promyelocytic leukemia. A review of literature. Am J Med65: 673–677, 1978.
11.
BakerR.D.Leukopenia and therapy in leukemia as factors predisposing to fatal mycoses. Mucormycosis, aspergillosis and cryptococcosis. Am J Clin Pathol37: 358–373, 1962.
12.
GurwithM.J., BruntonJ.L., LankB.A., RonaldA.R., HardingG.K.M.Granulocytopenia in hospitalized patients. I, Prognostic factors and etiology of fever. Am J Med64: 121–126, 1978.
SingerC., KaplanM.H., ArmstrongD.Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med62: 731–742, 1977.
17.
DeGregorioM.W., LeeW.M.F., LinkerC.A., JacobsR.A., RiesC.A.Fungal infections in patients with acute leukemia. Am J Med73: 543–548, 1982.
18.
MeyerR.D., RosenP., ArmstrongD.Phycomycosis complicating leukemia and lymphoma. Ann Intern Med77: 871–879, 1972.
19.
McGillT.J., SimpsonG., HealyG.B.Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope90: 748–754, 1980.
20.
Meunier-CarpentierF.Chemoprophylaxis of fungal infections. Am J Med76: 652–656, 1984.
21.
PizzoP.A., RobichaudK.J., GillF.A., WitebskyF.G.Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med72: 101–111, 1982.
22.
PizzoP.A., CommersJ., CottonD., GressJ., HathornJ., HiemenzJ., LongoD., MarshallD., RobichaudK.J.Approaching the controversies in antibacterial management of cancer patients. Am J Med76: 436–449, 1984.
23.
HolleranW.M., WilburJ.R., DeGregorioM.W.Empiric amphotericin B therapy in patients with acute leukemia. Rev Infect Dis7: 619–624, 1985.
24.
BennettJ.E.Chemotherapy of systemic mycoses. N Engl J Med290: 320–323, 1974.
25.
HermansP.E., KeysT.F.Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc58: 223–231, 1983.
26.
GoldJ.W.M.Opportunistic fungal infections in patients with neoplastic disease. Am J Med76: 458–463, 1984.
27.
BennettJ.E.Flucytosine. Ann Intern Med86: 319–322, 1977.
28.
BennettJ.E., DismukesW.E., DumaR.J., MedoffG., SandeM.A., GallisH., LeonardJ., FieldsB.T., BradshawM., HaywoodH., McGeeZ.A., CateT.R., CobbsC.G., WarnerJ.F., AilingD.W.A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med301: 126–131, 1979.
29.
Meunier-CarpentierF.Treatment of mycoses in cancer patients. Am J Med74 (suppl 1B): 74–79, 1983.
30.
UtzJ.P.Chemotherapy of the systemic mycoses. Med Clin North Am66: 221–233, 1982.
31.
Drugs for treatment of systemic fungal infections. Med Lett Drugs Ther28(711): 41–44, 1986.
